J S Johansen1, J R Kirwan, P A Price, M Sharif. 1. Department of Rheumatology, Hvidovre Hospital, University of Copenhagen, Denmark. julia.johansen@post3.tele.dk
Abstract
OBJECTIVE: YKL-40 is a secretory glycoprotein of chondrocytes, synovial cells, macrophages, and neutrophils. The aims were to determine serum YKL-40 in patients with early rheumatoid arthritis (RA) and seek associations with early joint erosions. METHODS: YKL-40 was measured by ELISA in serum samples collected every three month for 36 months from patients with early RA. The patients were treated with DMARDs and some were allocated to additional prednisolone. RESULTS: Serum YKL-40 was higher in RA patients compared with controls (98 vs. 42 microg/l, p<0.001). The mean serum YKL-40 during the study correlated with the progression in Larsen score (Pearson's test: p=0.004). Patients with a persistently high serum YKL-40 had larger progression in Larsen score compared with patients with normal serum YKL-40 (median progression: 7 vs. 0, p=0.003). CONCLUSION: These data suggest that elevated serum YKL-40 is related to progression in joint destruction in early RA patients.
OBJECTIVE:YKL-40 is a secretory glycoprotein of chondrocytes, synovial cells, macrophages, and neutrophils. The aims were to determine serum YKL-40 in patients with early rheumatoid arthritis (RA) and seek associations with early joint erosions. METHODS:YKL-40 was measured by ELISA in serum samples collected every three month for 36 months from patients with early RA. The patients were treated with DMARDs and some were allocated to additional prednisolone. RESULTS: Serum YKL-40 was higher in RApatients compared with controls (98 vs. 42 microg/l, p<0.001). The mean serum YKL-40 during the study correlated with the progression in Larsen score (Pearson's test: p=0.004). Patients with a persistently high serum YKL-40 had larger progression in Larsen score compared with patients with normal serum YKL-40 (median progression: 7 vs. 0, p=0.003). CONCLUSION: These data suggest that elevated serum YKL-40 is related to progression in joint destruction in early RApatients.
Authors: Paloma B Liton; Xialin Liu; W Daniel Stamer; Pratap Challa; David L Epstein; Pedro Gonzalez Journal: Invest Ophthalmol Vis Sci Date: 2005-01 Impact factor: 4.799
Authors: Ryan E Feaver; Banumathi K Cole; Mark J Lawson; Stephen A Hoang; Svetlana Marukian; Brett R Blackman; Robert A Figler; Arun J Sanyal; Brian R Wamhoff; Ajit Dash Journal: JCI Insight Date: 2016-12-08
Authors: Sung Soo Ahn; Taejun Yoon; Yong-Beom Park; Maria Prendecki; Gurjeet Bhangal; Stephen P McAdoo; Sang-Won Lee Journal: Arthritis Res Ther Date: 2021-03-08 Impact factor: 5.156
Authors: Signe Modvig; Matilda Degn; Henrik Horwitz; Stig P Cramer; Henrik B W Larsson; Benedikte Wanscher; Finn Sellebjerg; Jette L Frederiksen Journal: PLoS One Date: 2013-10-08 Impact factor: 3.240